In 2023, Edwards Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Edwards Lifesciences has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences amounted to 52,369 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of Edwards Lifesciences were 16,120 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2018, Edwards Lifesciences's Scope 1 emissions have increased by 27.34%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Edwards Lifesciences's Scope 1 emissions decreased by 10.64%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2023, Edwards Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 23,783 tCOâ‚‚e using the market-based method, and 36,249 tCOâ‚‚e using the location-based method.
Since 2018, Edwards Lifesciences's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 28.92%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Edwards Lifesciences's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Edwards Lifesciences 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2023, Edwards Lifesciences reported its Scope 2 emissions using the market-based method and using the location-based method.
In 2023, Edwards Lifesciences reported 571,975 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Edwards Lifesciences includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
In 2023, Edwards Lifesciences reported total Scope 3 emissions of 571,975 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 95% of these emissions originated from upstream activities such as purchased goods and capital goods, while 5% came from downstream activities like product use, distribution, and end-of-life treatment.
Since 2018, Edwards Lifesciences's Scope 3 emissions have increased by 1,111.71%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), Edwards Lifesciences's Scope 3 emissions increased by 12.07%, suggesting that the company faced challenges in reducing emissions across its value chain.
In 2023, Edwards Lifesciences reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2023, the largest contributors to Edwards Lifesciences's Scope 3 emissions were:
In 2023, Edwards Lifesciences reported a total carbon footprint of 624,344 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 10.7% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Edwards Lifesciences's total carbon footprint was Scope 3 emissions, accounting for 91.61% of the company's total carbon footprint, followed by Scope 2 emissions at 5.81%.